Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain

  1. Barrachina-Martinez, I.
  2. Vivas-Consuelo, D.
  3. Reyes-Santias, F.
Aldizkaria:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379 1473-7167

Argitalpen urtea: 2021

Alea: 21

Zenbakia: 5

Orrialdeak: 1081-1090

Mota: Artikulua

DOI: 10.1080/14737167.2021.1838899 GOOGLE SCHOLAR